United States News Todas as matérias

Kazia Therapeutics (NASDAQ:KZIA) reported preclinical data showing its PI3K/mTOR inhibitor paxalisib reduced tumor burden by 52% in an MSS/pMMR colorectal cancer model.

Comstock Resources (NYSE:CRK) signed a binding letter of intent with SOCAR for the sale of non-operated working interests in its Legacy and Western Haynesville upstream assets and a 15% stake in Pinnacle Gas Services for $1.65 billion in cash.

Descartes Systems Group (NASDAQ:DSGX) acquired Extensiv, a California-based provider of AI-enabled warehouse management and omnichannel fulfillment solutions, for approximately $120 million.

Kazia Therapeutics (NASDAQ:KZIA) reported preclinical results showing its PI3K/mTOR inhibitor paxalisib produced antitumor activity when combined with standard therapies in HR+/HER2- breast cancer models.

RedHill Biopharma (NASDAQ:RDHL) acquired exclusive global commercialization rights to Rebyota and exclusive U.S. rights to Clenpiq from Ferring Pharmaceuticals in a transaction focused on expanding its gastrointestinal business.

Adicet Bio (NASDAQ:ACET) completed the last patient visit for the planned Phase 1 safety and efficacy analysis of prulacabtagene leucel (prula-cel) in patients with systemic lupus erythematosus with or without lupus nephritis.

Bunge Global (NYSE:BG) agreed to sell its two sugarcane mills in São Paulo, Brazil, to COFCO International as part of the company’s strategic business priorities.

AstraZeneca (NASDAQ:AZN) completed its exclusive license agreement with Dizal Pharmaceutical for worldwide rights to develop and commercialize ZEGFROVY (sunvozertinib), an oral EGFR inhibitor for patients with lung cancer.

Medtronic (NYSE:MDT) reported first quarter fiscal 2027 revenue of $9.756 billion, up 13.7% year over year on both reported and organic bases, including an estimated $570 million benefit from an additional fiscal week.

MiniMed (NASDAQ:MMED) reported first quarter fiscal 2027 net sales of $843 million, increasing 16.6% year over year on a reported basis and 15.8% organically.

Regis Corporation (NASDAQ:RGS) reported fourth quarter fiscal 2026 revenue of $56 million, down from $60.4 million in the prior-year quarter, while operating income reached $6.6 million.

Novartis (NYSE:NVS) reported positive Phase 3 REMODEL-1 and REMODEL-2 trial results showing remibrutinib reduced annualized relapse rates compared with teriflunomide in adults with relapsing multiple sclerosis.

NIO (NYSE:NIO) reported second quarter 2026 total revenue of RMB32.1 billion (US$4.7 billion), up 69.1% year over year, supported by higher vehicle sales across its brands.

Natera (NASDAQ:NTRA) announced the publication of new data in Blood Neoplasia showing that its Signatera circulating tumor DNA test provided prognostic and predictive information for patients with newly diagnosed and relapsed or refractory lymphoma.

Oil prices increased on Tuesday as renewed fighting between the United States and Iran raised concerns about potential supply disruptions from the Middle East, a major crude-producing region.

Li Auto (NASDAQ:LI) reported August 2026 deliveries of 37,679 vehicles, bringing the company’s cumulative deliveries to 1,801,834 vehicles as of August 31, 2026.

NIO (NYSE:NIO) reported August 2026 deliveries of 35,836 vehicles, up 14.5% year over year, including deliveries from its NIO, ONVO, and FIREFLY vehicle brands.

XPENG (NYSE:XPEV) reported August 2026 vehicle deliveries of 39,107 units, representing a 4% increase compared with the same period last year.

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo received European Union approval for Enhertu (trastuzumab deruxtecan) combined with pertuzumab as a first-line treatment for adults with unresectable or metastatic HER2-positive breast cancer.

Elbit Systems (NASDAQ:ESLT) signed contracts totaling approximately $270 million with an international customer to supply advanced intelligence, surveillance, reconnaissance, and targeting systems over a period of up to six years.

Sasol (NYSE:SSL) reported audited financial results for the year ended June 30, 2026, with turnover rising 9% to R272.1 billion and adjusted EBITDA increasing 17% to approximately R61 billion.

S&P Global (NYSE:SPGI) completed its acquisition of datacenterHawk, adding proprietary intelligence on global data center, fiber optic, and related infrastructure markets to S&P Global Energy.

Australia's financial crimes regulator launched an investigation into Western Union Financial Services and parent entity Western Union (NYSE:WU).

Pyxis Tankers (NASDAQ:PXS) reported second quarter 2026 revenue of $12.1 million, up 32.6% year over year, with net income attributable to common shareholders of $2.8 million compared with a $2 million loss in the prior-year period.